The digital health start-up SocialDiabetes, a CataloniaBio & HealthTech member, and the Irish firm Innovation Zed Ltd have signed an agreement to enhance health outcomes for people with type 1 and type 2 diabetes.
The companies will pursue joint efforts to sell their products as a single integrated system.
Innovation Zed has developed InsulCheck Connect, an insulin pen add-on technology which automatically collects essential usage data that informs users of their injection history. SocialDiabetes is one of the most established diabetes management software providers.
"Therapy adherence is a serious issue and we are dedicated to making a cumbersome task as easy as it could be" says María Jesús Salido, CEO of SocialDiabetes.
You may also be interested in:
Comments